Glenview Capital Management - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 299 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
Glenview Capital Management ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2021$132,713,000
-13.5%
8,102,119
-11.1%
2.41%
-5.2%
Q2 2021$153,414,000
-47.8%
9,115,521
-43.4%
2.54%
-49.1%
Q1 2021$294,063,000
+5.9%
16,104,222
+5.5%
4.98%
-21.8%
Q4 2020$277,741,000
-7.3%
15,260,512
-9.1%
6.37%
-32.3%
Q3 2020$299,508,000
+3.1%
16,788,589
+3.7%
9.40%
+17.4%
Q2 2020$290,382,000
-4.1%
16,195,310
-18.8%
8.00%
-2.8%
Q1 2020$302,947,000
-49.8%
19,956,999
-34.7%
8.24%
+55.9%
Q4 2019$603,397,000
+27.8%
30,582,721
+11.4%
5.28%
+6.4%
Q3 2019$472,034,000
+0.9%
27,443,846
+3.8%
4.97%
+17.1%
Q2 2019$467,826,000
-12.0%
26,430,828
+1.2%
4.24%
-10.7%
Q1 2019$531,915,00026,112,6604.75%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2021
NameSharesValueWeighting ↓
Adelphi Capital LLP 7,931,116$140,381,00032.92%
Endurant Capital Management LP 932,967$16,514,0006.51%
Glenview Capital Management 26,430,828$467,826,0004.24%
Paulson & Co. 13,244,711$234,431,0003.98%
Blackcrane Capital, LLC 172,955$3,061,0003.88%
NINE MASTS CAPITAL Ltd 1,474,286$26,146,0003.74%
Velanne Asset Management Ltd 286,640$5,074,0003.22%
LMR Partners LLP 4,563,591$80,884,0002.95%
SECTOR GAMMA AS 796,299$14,094,0002.26%
MFN Partners Management, LP 785,000$13,895,0002.21%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders